Search
Search results for "other agents modifying bone structure and mineralization. antiresorptive agent for oncology use."
Pharmaceutical Forms:
Vial containing 120mg of Denosumab in 1.7mL of solution for injection. (70mg/mL) .
Subcutaneous administration
Therapeutic Area: Other agents modifying bone structure and mineralization. Antiresorptive agent for oncology use.
Active Ingredient: Denosumab
